In this video from SC16, Steve Conway from IDC moderates a panel discussion on Precision Medicine.
Leading voices from the frontlines of clinical care, medical research, public policy and pharmaceutical R&D will share diverse perspectives on the future of precision medicine. Emerging technology is transforming the practice of medicine from an analog field of paper notebooks, textbooks and charts into a digital domain. This transition may emerge as one the most fundamental important tipping points since the discovery of penicillin, molecular biology, and the sequencing of the human genome. Recently, DOE Secretary Moniz, VA Secretary MacDonald, NCI Director Lowy and the GSK CEO Andrew Witty announced that the Nation’s leading supercomputers would be applied to the challenge of the Cancer Moonshot initiative. This partnership of nontraditional groups, collectively see the path to unraveling the complexities of cancer through the power of new machines, operating systems, and applications that leverage simulations, data science and artificial intelligence to accelerate bringing precision oncology to the patients that are waiting. This initiative is one of many research efforts in the race to solve some of our most challenging medical problems.
As detailed in this panel discussion, the success of all of these research programs hinge on harnessing the power of HPC to analyze volumes of complex genomics and other biological datasets that simply can’t be processed by humans alone. The challenge for our community will be to develop the computing tools and services needed to transform how we think about disease and bring us closer to the precision medicine future.
SC16 Invited Panelists:
- Dr. Timothy Buchman, Emory University: Professor of Surgery, Emory University School of Medicine; Professor of Anesthesiology, Emory University School of Medicine; Director, Emory Critical Care Center, Emory University School of Medicine; Chief, Critical Care Service, Emory Healthcare
- Dr. Mitchell Cohen, Director of Surgery, Denver Health Medical Center; Professor, University of Colorado School of Medicine. Cohen’s research portfolio includes research funded by the U.S. Department of Defense, the Patient-Centered Outcomes Research Institute, and the National Institutes of Health.
- Fred Streitz, Chief Computational Scientist Director, HPC Innovation Center
Director, Institute for Scientific Computing Research at LLNL - Dr. Warren Kibbe, Director, Center for Biomedical Informatics and Information Technology (CBIIT)
- Dr. Martha Head, Senior Director, The Noldor; Acting Head, Insights from Data at GlaxoSmithKline Pharmaceuticals
- Steve Scott, Senior VP & CTO, Cray Inc
See our complete coverage of SC16
